MANORGNSE30 May 2022

Mangalam Organics Limited

3,556words
1turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
I LManqalam 4:I frorganits Limited Head Office : 812, Tulsiani Chambers, 212, Nariman Point, Mumbai - 4OO 021 Tel.-.91-22-4928 4A8S I 2282 4ABg Fax : 91-22492A 4081 I 2284 1
5000 MT
full fledge. Mangalam Organics Ltd. commenced commercial production of additional plant of 5000 MT on 31st January 2022. 5 Our Business Segments B2B- Terpene Revenue break-up • Camphor: Relig
80%
aints, cleaning and degreasing agents • Sodium Acetate: Textile and dyes industry, Leather tanning 80% Terpene Operations B2B - Synthetic Resin • Terpene Phenolic Resin - Adhesives • Alkyl Phenolic
5%
astic compounds for road marking, hot melts and glues susceptible to pressure, insulation finishes 5% Synthetic Resin Operations B2C - Retail Operations • CamPure - Homecare and personal care prod
10%
ucts based on Camphor • Mangalam - Camphor tablets for pious uses • Private Labelling Initiatives 10% In FY21 15% Retail Operations in FY22 6 Our Business Model Chemistry Capabilities B2C Re
15%
Camphor • Mangalam - Camphor tablets for pious uses • Private Labelling Initiatives 10% In FY21 15% Retail Operations in FY22 6 Our Business Model Chemistry Capabilities B2C Retailing Exper
rs 8
sin Camphor| Dipentene | Sodium Acetate Terpene Phenolic Resin | Alkyl Phenolic Resin | Rosin Esters 8 Our Product Portfolio – B2C Business-to-Consumer CamPure - Homecare and personal care products bas
45%
ns 10 Financials FY22 Consolidated Financial Performance Revenues (Rs. Crs) EBITDA (Rs. Crs) +45% 490.6 338.2 -29% 127.8 91.0 PAT (Rs. Crs) -37% 84.6 53.7 FY21 FY22 FY21 FY22 FY21 FY
29%
FY22 Consolidated Financial Performance Revenues (Rs. Crs) EBITDA (Rs. Crs) +45% 490.6 338.2 -29% 127.8 91.0 PAT (Rs. Crs) -37% 84.6 53.7 FY21 FY22 FY21 FY22 FY21 FY22 EBITDA Margin (%
37%
mance Revenues (Rs. Crs) EBITDA (Rs. Crs) +45% 490.6 338.2 -29% 127.8 91.0 PAT (Rs. Crs) -37% 84.6 53.7 FY21 FY22 FY21 FY22 FY21 FY22 EBITDA Margin (%) 1930 bps 37.8% PAT Margin (%)
1930 bps
27.8 91.0 PAT (Rs. Crs) -37% 84.6 53.7 FY21 FY22 FY21 FY22 FY21 FY22 EBITDA Margin (%) 1930 bps 37.8% PAT Margin (%) 1410 bps 25.0% 18.5% 10.9% • • • • Revenue growth of 45% in FY22 vs
37.8%
PAT (Rs. Crs) -37% 84.6 53.7 FY21 FY22 FY21 FY22 FY21 FY22 EBITDA Margin (%) 1930 bps 37.8% PAT Margin (%) 1410 bps 25.0% 18.5% 10.9% • • • • Revenue growth of 45% in FY22 vs FY21.
Guidance — 4 items
Registered Office I Factory
opening
No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company.
Registered Office I Factory
opening
costs lead to decline in Company continues its efforts on improving efficiencies and margins going forward.
Registered Office I Factory
opening
it is estimated that Going forward, India will start using camphor for innovative hygiene products as in the pictures above.
Registered Office I Factory
opening
B2C – Target retail market with e-Commerce Pin Codes serviced from e-Commerce orders 12,000 + 9,000 2,500 3,700 FY19 FY20 FY21 FY22 33 Corporate Social Responsibility Renovation of Healthcare Centre Renovation of School Investor Presentation 34 Manufacturing Facility Our Manufacturing Facilities PRODUCTION FACILITY Our plant is located on the Mumbai – Pune expressway in Kumbhivali.
Advertisement
Risks & concerns — 1 flagged
costs lead to decline in Company continues its efforts on improving efficiencies and margins going forward.
Registered Office I Factory
Speaking time
Registered Office I Factory
1
Advertisement
Opening remarks
Registered Office I Factory
Village Kumbhivali, Savroli-Kharpada Road, Khalapur-410 2A2, Dist. Raigad (Maharashtra) Tel. 02192 - 276140 + Date: May 30,2022 -To BSE Limited Listing & Compliance Departrnent Phiroze Jeejeebhoy Towers, Dalal Street, Fort Mumbai - 400001. The National Stock Exchange of India Limited Listing & Compliance Departrnent Exchange Plaza, C-L Block G, \andra Kurla iomplex, Bandra (E), Mumbai - 400051 Security Code: 5L44L8 NSE Symbol MANORG Dear Sir/Madam, Sub: Investor Presentation for Q4 &W 2021-22 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose a copy of Investor Presentation for the Quarter and Financial Year ended March 3'J,,2022 (Q and Fy 2021,-22). This Investor Presentation may also be accessed on the website of the Company at www.mangalamorganics. com. We request you to disseminate the above information on your website. Thanking you, Yours faithfully, For Mangalam Organics Limited Lukha Company Secretary EncL As
Advertisement
← All transcriptsMANORG stock page →